| . | Human RAD17–RFC–9–1–1–DNA . |
|---|---|
| Magnification | 96000 |
| Voltage (kV) | 300 |
| Electron exposure (e–/Å2) | 39.4 |
| Defocus range (μm) | −1 to −3.0 |
| Pixel size (Å) | 0.86 |
| Symmetry imposed | C1 |
| Initial particle images (no.) | 2479092 |
| Final particle images (no.) | 150626 |
| Map resolution (Å) | 3.59 |
| FSC threshold | 0.143 |
| Refinement | |
| Initial model used (PDB code) | 6VVO, 3G65, AF_075943 |
| Map resolution range (Å) | 3.43–14.26 |
| Map sharpening B factor (Å) | −6.05 |
| Non-hydrogen atoms | 20633 |
| Protein residues | 2513 |
| DNA residues | 32 |
| Co-factor residues | 5 |
| B-factors (Å2) | |
| Protein | 32.7 |
| DNA | 40.8 |
| Co-factor | 43.1 |
| R.m.s. deviations | |
| Bond lengths (Å) | 0.004 |
| Bond angles (°) | 0.80 |
| Validation | |
| MolProbity score | 1.98 |
| Clashscore | 10.32 |
| Poor rotamers (%) | 0.77 |
| Ramachandran plot | |
| Favoured (%) | 93.16 |
| Allowed (%) | 6.40 |
| Disallowed (%) | 0.45 |
| . | Human RAD17–RFC–9–1–1–DNA . |
|---|---|
| Magnification | 96000 |
| Voltage (kV) | 300 |
| Electron exposure (e–/Å2) | 39.4 |
| Defocus range (μm) | −1 to −3.0 |
| Pixel size (Å) | 0.86 |
| Symmetry imposed | C1 |
| Initial particle images (no.) | 2479092 |
| Final particle images (no.) | 150626 |
| Map resolution (Å) | 3.59 |
| FSC threshold | 0.143 |
| Refinement | |
| Initial model used (PDB code) | 6VVO, 3G65, AF_075943 |
| Map resolution range (Å) | 3.43–14.26 |
| Map sharpening B factor (Å) | −6.05 |
| Non-hydrogen atoms | 20633 |
| Protein residues | 2513 |
| DNA residues | 32 |
| Co-factor residues | 5 |
| B-factors (Å2) | |
| Protein | 32.7 |
| DNA | 40.8 |
| Co-factor | 43.1 |
| R.m.s. deviations | |
| Bond lengths (Å) | 0.004 |
| Bond angles (°) | 0.80 |
| Validation | |
| MolProbity score | 1.98 |
| Clashscore | 10.32 |
| Poor rotamers (%) | 0.77 |
| Ramachandran plot | |
| Favoured (%) | 93.16 |
| Allowed (%) | 6.40 |
| Disallowed (%) | 0.45 |
| . | Human RAD17–RFC–9–1–1–DNA . |
|---|---|
| Magnification | 96000 |
| Voltage (kV) | 300 |
| Electron exposure (e–/Å2) | 39.4 |
| Defocus range (μm) | −1 to −3.0 |
| Pixel size (Å) | 0.86 |
| Symmetry imposed | C1 |
| Initial particle images (no.) | 2479092 |
| Final particle images (no.) | 150626 |
| Map resolution (Å) | 3.59 |
| FSC threshold | 0.143 |
| Refinement | |
| Initial model used (PDB code) | 6VVO, 3G65, AF_075943 |
| Map resolution range (Å) | 3.43–14.26 |
| Map sharpening B factor (Å) | −6.05 |
| Non-hydrogen atoms | 20633 |
| Protein residues | 2513 |
| DNA residues | 32 |
| Co-factor residues | 5 |
| B-factors (Å2) | |
| Protein | 32.7 |
| DNA | 40.8 |
| Co-factor | 43.1 |
| R.m.s. deviations | |
| Bond lengths (Å) | 0.004 |
| Bond angles (°) | 0.80 |
| Validation | |
| MolProbity score | 1.98 |
| Clashscore | 10.32 |
| Poor rotamers (%) | 0.77 |
| Ramachandran plot | |
| Favoured (%) | 93.16 |
| Allowed (%) | 6.40 |
| Disallowed (%) | 0.45 |
| . | Human RAD17–RFC–9–1–1–DNA . |
|---|---|
| Magnification | 96000 |
| Voltage (kV) | 300 |
| Electron exposure (e–/Å2) | 39.4 |
| Defocus range (μm) | −1 to −3.0 |
| Pixel size (Å) | 0.86 |
| Symmetry imposed | C1 |
| Initial particle images (no.) | 2479092 |
| Final particle images (no.) | 150626 |
| Map resolution (Å) | 3.59 |
| FSC threshold | 0.143 |
| Refinement | |
| Initial model used (PDB code) | 6VVO, 3G65, AF_075943 |
| Map resolution range (Å) | 3.43–14.26 |
| Map sharpening B factor (Å) | −6.05 |
| Non-hydrogen atoms | 20633 |
| Protein residues | 2513 |
| DNA residues | 32 |
| Co-factor residues | 5 |
| B-factors (Å2) | |
| Protein | 32.7 |
| DNA | 40.8 |
| Co-factor | 43.1 |
| R.m.s. deviations | |
| Bond lengths (Å) | 0.004 |
| Bond angles (°) | 0.80 |
| Validation | |
| MolProbity score | 1.98 |
| Clashscore | 10.32 |
| Poor rotamers (%) | 0.77 |
| Ramachandran plot | |
| Favoured (%) | 93.16 |
| Allowed (%) | 6.40 |
| Disallowed (%) | 0.45 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
